The innovative HAProLink™ technology enables strong bonding between Fibrinogen and Hyaluronic Acid (HA), creating a stable biological gel structure that mimics the natural extracellular matrix (ECM) of joint tissue.
The synthesis of hybrid proteoglycans not only enhances joint elasticity and lubrication but also provides an ideal biological environment to support cartilage regeneration, reduce inflammation, and improve mobility.
This is why RegenoGel™ stands out from conventional viscosupplementation methods — it doesn't just "supplement" the joint but actively stimulates the body’s natural repair mechanisms.
